Polyethylene glycol (PEG) for Peripheral Nerve Injuries
This study is evaluating whether a new technique for repairing peripheral nerve injuries may help improve recovery.
See full descriptionAbout the trial for Peripheral Nerve Injuries
Treatment Groups
This trial involves 3 different treatments. Polyethylene Glycol (PEG) is the primary treatment being studied. Participants will be divided into 3 treatment groups. There is no placebo group. The treatments being tested are in Phase 1 and are in the first stage of evaluation with people.
About The Treatment
Eligibility
This trial is for patients born any sex aged 18 and older. There are 7 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Polyethylene glycol (PEG) will improve 1 primary outcome in patients with Peripheral Nerve Injuries. Measurement will happen over the course of 12 months.
Who is running the study
Principal InvestigatorPatient Q & A Section
Is polyethylene glycol (peg) safe for people?
PEG-based solutions may be effective in reducing pain in selected people with chronic pelvic pain syndrome. The evidence base for PEG as adjunctive therapy to opioids, however, is limited. The evidence for possible long-term benefits is also limited, and the most effective PEG-based solution requires further study.
What is the average age someone gets peripheral nerve injuries?
The literature is ambiguous regarding the average age of peripheral nerve injuries; the vast majority of the available data points towards an older age of onset in the literature by decades. This age may have an impact on the patient's expectations in rehabilitation programmes.
What are the signs of peripheral nerve injuries?
The symptoms of a PNI depend largely on the position of the lesion. Patients presenting to the emergency department with unilateral lower limb symptoms may have a lesion at the upper thigh or lower leg. Patients with a bilateral or unilateral leg PNI presenting to the emergency department with pain in the feet, lower back or buttocks may have a lesion in the pelvis or lower back. Patients presenting with pain in the feet and lower leg are likely to have sciatica. Patients presenting with unilateral buttock pain, unilateral groin pain and pain in the foot have lesions in the lower leg or foot with sciatica a possibility. Any of these features should raise the possibility of PNI and requires further investigation and management.
What are common treatments for peripheral nerve injuries?
The most commonly used treatments are for acute nerve injuries. Nerves with nerve pain were relieved by splinting, compression, or decompression at 9.8% of cases in a study conducted by a pediatric emergency physician. In general, there are no studies that compare the outcome of each treatment; however, in all three treatments, outcome was mostly good.
Can peripheral nerve injuries be cured?
The current scientific data does not support the proposition that peripheral nerve injuries can be successfully cured. Clinical and animal studies have demonstrated the potential harmful consequences of regenerating neural axons after severe axon transection injuries. As such, nerve regenerative medicine is a promising area for more research in the future to find therapies for patients with injuries that are serious, debilitating, and often irreversible.
How many people get peripheral nerve injuries a year in the United States?
The American Medical Association estimates 7.4 million American children have an NIs in their lifetime. In a recent study, findings suggests that around 15% of them have serious injury, resulting in more than 2 million long-term physical and economic damage to their families.
What causes peripheral nerve injuries?
As traumatic nerve injuries result in functional deficits, the current investigation focuses on a model of chronic nerve injury resulting in an irreversible and prolonged decline in the function of multiple sensory and motor neurons. By studying these injuries in this model, it is possible to discover possible molecular mechanisms for nerve damage and to elucidate the role of the local microenvironment surrounding peripheral nerve injuries.
How serious can peripheral nerve injuries be?
Patients with serious peripheral nerve injuries are often left to suffer a significant long-term disability. While the risk of persistent disabling disability may be increased, the risk of death is not significantly increased. When a significant deficit after injury has become apparent or becomes evident, it can be treated and managed as a chronic condition.
Have there been other clinical trials involving polyethylene glycol (peg)?
Recent findings showed PEG did not work for people with nerve damage. There is more evidence that PEG is not appropriate to use for people suffering from nerve damage.
What is peripheral nerve injuries?
Peripheral nerve injuries arise when a vital nerve is cut or broken. These injuries affect movement and sensation, often causing disabling symptoms. This is true in either the upper or lower limbs. Peripheral nerves make up the largest part of a limb, including the nerves, blood vessels and muscles, and most peripheral nerve injuries have repercussions on the limb. Therefore, diagnosis and treatment of peripheral nerve injuries requires the knowledge of the anatomy of the limb and an examination of the function of the limb. Peripheral nerve injuries are not usually fatal and are managed by the use of pain medicines and exercise. Peripheral nerve injuries usually only recover completely when the nerve is reconstructed.\n\nIn 2013, the US hospital market was $1.
Who should consider clinical trials for peripheral nerve injuries?
Clinical trials for peripheral nerve injuries need to be targeted towards those suffering from chronic pain or those with neurological disability that are refractory to conventional treatment.
Does peripheral nerve injuries run in families?
We did not find any evidence supporting a familial pattern of peripheral nerve injuries. Peripheral neuropathies are probably multifactorial in etiology and do not run in families.